Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for MICR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2023 -0.0394M
December 31, 2022 -0.1291M
September 30, 2022 0.0399M
June 30, 2022 -0.0494M
March 31, 2022 -0.0175M
December 31, 2021 -0.0485M
September 30, 2021 -0.4379M
June 30, 2021 3.581M
March 31, 2021 -0.1337M
December 31, 2020 -0.1246M
September 30, 2020 -0.1458M
June 30, 2020 -0.1886M
March 31, 2020 -0.015M
December 31, 2019 -0.0072M
September 30, 2019 0.6731M
June 30, 2019 -0.0333M
March 31, 2019 -0.1057M
December 31, 2018 -0.337M
September 30, 2018 -0.2774M
June 30, 2018 -0.0862M
March 31, 2018 -0.0955M
December 31, 2017 -0.0559M
September 30, 2017 -0.1118M
June 30, 2017 -0.276M
March 31, 2017 -0.4757M
Date Value
December 31, 2016 -0.298M
September 30, 2016 -0.1092M
June 30, 2016 -0.5869M
March 31, 2016 -0.3733M
December 31, 2015 -0.1102M
September 30, 2015 -0.2738M
June 30, 2015 -0.5425M
March 31, 2015 -0.2264M
December 31, 2014 -0.4244M
September 30, 2014 -0.2693M
June 30, 2014 -0.421M
March 31, 2014 -0.392M
December 31, 2013 -0.4027M
September 30, 2013 -0.5338M
June 30, 2013 -0.397M
March 31, 2013 -0.0176M
December 31, 2012 -0.1667M
September 30, 2012 -0.0732M
June 30, 2012 -0.4924M
March 31, 2012 -0.5065M
December 31, 2011 -1.741M
September 30, 2011 -0.6637M
June 30, 2011 -0.3783M
March 31, 2011 -0.4026M
December 31, 2010 -0.5128M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Accuray, Inc. -1.353M
Orthofix Medical, Inc. -12.57M
ResMed, Inc. -383.65M
Rockwell Medical, Inc. -0.487M
Microbot Medical, Inc. 4.471M